Stocks Health care DRIO
NASDAQ · Health careDarioHealth Corp. (DRIO)
DarioHealth Corp. brought in $21M of revenue over the twelve months to June 30, 2026, down 22.6% from a year earlier. It posted a net loss of $35.7M. In fiscal 2025 capital spending exceeded operating cash flow by $26.1M. At June 30, 2026 it held $6.6M in cash against $31.1M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 11, 2026.
Key facts about DarioHealth Corp.
- Net worth
- DarioHealth Corp. has a market value (market cap) of $23.4M at the latest share price, and shareholders' equity of $55.1M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $22.4M (-17.3% year on year), with a net loss of $41.7M. Over the 12 months to June 30, 2026: revenue $21M, net loss $35.7M.
- Cash flow
- In fiscal 2025 operations used $25.9M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 11, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- DarioHealth Corp.'s next report is expected around November 12, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
What DarioHealth Corp. does
DarioHealth Corp. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker DRIO.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $22.4M | -$41.7M | $10.12 | -$26.1M |
| 2024 | $27M | -$42.7M | $12.27 | -$38.7M |
| 2023 | $20.4M | -$59.4M | $38.82 | -$31M |
| 2022 | $27.7M | -$62.2M | $51.09 | -$48.3M |
| 2021 | $20.5M | -$76.8M | $81.87 | -$50.7M |
| 2020 | $7.6M | -$29.4M | $80.66 | -$17.9M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where DRIO ranks in Health care
Latest SEC filings
What DarioHealth Corp. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 4, 2026
- August 21, 2026
- August 11, 2026Quarterly report 10-Q · period to June 30, 2026Revenue fell 3.6% to $5.2M versus the same quarter last year; diluted EPS $0.85 versus $3.54.
- July 22, 2026
- July 10, 2026
- May 13, 2026Quarterly report 10-Q · period to March 31, 2026Revenue fell 17% to $5.6M versus the same quarter last year; diluted EPS $1.25 versus $2.87.
- May 7, 2026
- April 13, 2026
- March 30, 2026
- March 19, 2026
Insider trades
What the people running DarioHealth Corp. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 8 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| September 24, 2026 | Raphael ErezChief Executive Officer, Director | Received as pay | 297,000 | - |
| September 24, 2026 | Karah HilaDirector | Received as pay | 28,000 | - |
| September 24, 2026 | Matheis DennisDirector | Received as pay | 44,000 | - |
| September 24, 2026 | Franco-Yehuda ChenChief Financial Officer | Received as pay | 95,000 | - |
| September 24, 2026 | Shaked YoavDirector | Received as pay | 54,000 | - |
| September 24, 2026 | Mcgrath Dennis MDirector | Received as pay | 61,000 | - |
| September 24, 2026 | Stern Adam KDirector | Received as pay | 28,000 | - |
| September 24, 2026 | Palumbo John RDirector | Received as pay | 62,000 | - |
Who owns DRIO
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Craig Kallman 2015 Living Trust13G, passive with 1 related filers | 9.99% | December 16, 2025 |
| Nantahala Capital Management, LLC13G, passive with 2 related filers | 9.99% | February 13, 2026 |
| Tasso Partners, LLC13G, passive with 1 related filers | 9.99% | November 12, 2025 |
| Solid Financial LLC13G, passive | 5.6% | February 12, 2025 |
Largest institutional holders
Insiders
8 insiders reported holding 1,052,300 shares in total, about $2.5M at the last price.
| Holder | Shares |
|---|---|
| Raphael ErezChief Executive Officer, Director | 454,432 |
| Franco-Yehuda ChenChief Financial Officer | 125,000 |
| Mcgrath Dennis MDirector | 88,737 |
| Shaked YoavDirector | 87,582 |
| Matheis DennisDirector | 87,026 |
| Stern Adam KDirector | 84,05826,341 held indirectly |
| Palumbo John RDirector | 66,500 |
| Karah HilaDirector | 58,965 |
Questions about DRIO
What does DarioHealth Corp. do?
DarioHealth Corp. is a company in the Health care sector, listed on NASDAQ as DRIO. Its shares trade on NASDAQ under the ticker DRIO.
What is DarioHealth Corp.'s net worth?
DarioHealth Corp. has a market value (market cap) of $23.4M at the latest share price, and shareholders' equity of $55.1M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is DarioHealth Corp. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $35.7M on revenue of $21M.
How much revenue does DarioHealth Corp. make?
Over the twelve months to June 30, 2026 DarioHealth Corp. reported revenue of $21M. That is 22.6% less than a year earlier.
When did DarioHealth Corp. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 11, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 28, 2026.
When is DarioHealth Corp.'s next earnings report?
DarioHealth Corp.'s next report is expected around November 12, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare DRIO with
Follow DRIO
Get an email when DarioHealth Corp. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values DarioHealth Corp. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.